Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that Marc Jones, Non-Executive Director and Rajeshwar R. Bajaaj, Independent Director have ceased to be a Directors of the Company from close of the business hours on 24th July 2018.
The above information is a part of company’s filings submitted to BSE.